Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-

Slides:



Advertisements
Similar presentations
Agents Used in the Treatment of Hyperlipidemia
Advertisements

ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
CHOLESTEROL AND OUR LIVES الدهنيات وحياتنا
Lecture 5c 4 Feb 2013 Atherosclerosis - Functional Foods and Nutraceuticals.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Note Final Exam-please check final schedule Essays due-lateness unacceptable.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
© 2007 Thomson - Wadsworth Chapter 21 Nutrition & Disorders of the Heart & Blood Vessels.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
ANTIHYPERLIPIDEMIC DRUGS
1. pathology -2 points -loss of calcium from the bones -porous bone is formed -affects primarily women -1point Caused by –eg menopause -1-point Effects-
Nutrition & Heart Disease Key Concepts and Facts Heart disease is leading cause of death Dietary and lifestyle factors are important Diets that provide.
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Lecture 5b 3 Feb 2014 Atherosclerosis-Nutritional intervention- -emphasis should be on prevention-
Note Midterm - 4 March in class. Note Signal peptide-A sequence of amino acids that determine whether a protein will be formed on the rough endoplasmic.
Lecture 5c 3 Feb 2014 Atherosclerosis - Functional Foods and Nutraceuticals.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Note Midterm - 7 March in class. Note Signal peptide-A sequence of amino acids that determine whether a protein will be formed on the rough endoplasmic.
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
Note Midterm - 4 March in class. Note On Tuesday, February 5 th, the National Survey of Student Engagement (NSSE) opens for our first-year and senior.
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Case 4 Chang Chia-Chieh(Tony). Mr. Reyes was prescribed Lovastatin 20mg. b.i.d. and told to return in 6 weeks.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
Lecture 5b 4 Feb 2013 Atherosclerosis-Nutritional intervention- -emphasis should be on prevention-
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
MargiAnne Isaia, MD MPH Advanced Nutrition Diet and Dyslipidemia.
Cholesterol metabolism
Chapter 11 Diet and Health
Note Final Exam-please check final schedule.
Drugs for Lipid Disorders
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Note World Health Organisation indicated on 5 March
Formative Test.
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Lipids in Health and Disease
Cardiovascular System
Cardiovascular System
Cardiovascular System
Cardiovascular System
Lipoprotein(a), Cardiovascular Disease, and Contemporary Management
National Cholesterol Education Program
Drugs for Hyperlipidemias
Lipids in Health and Disease
Antilipidaemic agents
Antihyperlipidemic Drugs
Laboratory November 2017 End stage renal disease.
Laboratory 9- Week of November 2015
Note Final Exam-please check final schedule.
Cardiovascular System
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Note Final Exam-please check final schedule
Note Final Exam-please check final schedule.
Lipids in Health and Disease
Chapter 7 LIPIDS IN HEALTH & DISEASE
Note Final Exam-please check final schedule.
Major classes of drugs to reduce lipids
Low-Calorie Step I Diet
Cardiovascular System
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention- -emphasis should be on prevention-

Group activity A patient presents with severe atherosclerosis (severe stenosis and accompanying chest pains). From a clinical perspective is diet modification alone the best approach to reducing the risk of MI? Why or why not? If not then what are the other medical options available?

Lipids LCAT preference for GLA > LA > OA > AA> DHA LPL-preferences increase activity-no reports found CETP-preferences increase activity-no reports found

Blood Levels of concern- new ATP-NCEP guidelines issued 2004-diet approaches are constantly changing   HDL Addressed when triglycerides are addressed LDL including oxidized LDL Table 6, Fig 1,2 ATP main target of diet

Blood Levels of concern Lp(a)- diet does not alter (very tight genetic control)   Cholesterol -addressed when LDL is addressed Triglycerides- Fasting plasma-fish is an option, reduction in saturated fat-frequently dietary recommendations for LDL also take care of triglycerides

Blood Levels of concern Triglycerides -post-prandial-fish is an option –what does this say about LPL?   HDLc: LDLc ratio of < 0.2 – again emphasis is on LDL first

Blood Levels of concern Triglycerides and small dense LDL   As plasma triglyceride levels fall there is a smaller percentage of small dense LDL -reduce triglycerides as above Triglycerides and low HDLc -this is due to low LPL activity

Macrophages Increase B-carotene, vitamin E and C-jury is still out on these issues?

Platelets Platelet membrane fatty acid composition Phospholipase A2 and Cyclooxygenase  

Platelets Platelet membrane fluidity-reduce saturated fat and dietary cholesterol since they both decrease membrane fluidity  

Platelets- Interaction with lipoproteins HDL-lowers aggregation-no observed impact of nutrition (no studies done) here   LDL-elevates aggregation-no observed impact of nutrition (no studies done) here Lp (a)-depresses platelet aggregation though also thought to inhibit plasminogen activation no observed impact of nutrition (no studies done) here

Blood pressure   Reduce saturated fats and dietary cholesterol and increase pufa to improve artery patency -remember that plaque formation’s sequelae include calcium deposition that further reduces artery patency

-diets high in oleic acid (18:1 n-9) MAY result in weight loss Obesity -diets high in oleic acid (18:1 n-9) MAY result in weight loss   Renal Disease -see blood pressure Various Pathogens Adequate nutrient intake is critical to maintaining immune response

Nitric oxide -vasodilation, antiplatelet effects, also important in immune response   -high salt intake in salt sensitive individuals reduces NO production and may explain increased blood pressure due to NO factor -may also explain why MUFA lowers blood pressure -increased blood pressure can result in increased platelet reactivity

Nitric oxide decrease NO production can result in decreased immune response (pathogen impact)  

Diet drug interactions   Cholestyramine-lowers cholesterol by acting as a bile acid sequestrant -nausea, GI distress and constipation and can lead to fat soluble vitamin deficiencies Colestipol -lowers cholesterol by acting as a bile acid sequestrant is less likely than cholestyramine to cause the above problems but it can give constipation

Diet drug interactions Gemfibrozil - speeds up LPL action of VLDL and hence reduces triglycerides-can lead to nausea and GI distress   Statins (cholesterol lowering HMG-CoA synthase inhibitors)-lovastatin, pravastatin, simvastin) should not be given with grapefruit juice Limit alcohol content

Diet drug interactions Anticoagulants (eg aspirin) and hyper doses of vitamin E (> 2000 IU/day) should be limited -Coincidental high intakes of fish-to be avoided   -aspirin inhibits platelet function by inhibiting cyclooxygenase Aspirin can lead to folate and vitamin C deficiencies (potential heart disease consequences?)